Buckingham Capital Management (Ohio)’s Regeneron Pharmaceuticals REGN Stock Holding History

Buckingham Capital Management (Ohio)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-552	Closed	-$267K	–	122
2020 Q4	$267K	Sell	552 -282	-34%	-$152K	0.05%	104
2020 Q3	$467K	Sell	834 -215	-20%	-$130K	0.09%	92
2020 Q2	$654K	Sell	1,049 -547	-34%	-$310K	0.14%	84
2020 Q1	$779K	Sell	1,596 -689	-30%	-$284K	0.2%	78
2019 Q4	$858K	Sell	2,285 -857	-27%	-$288K	0.15%	98
2019 Q3	$872K	Buy	3,142 +2	+0.1%	+$592	0.16%	96
2019 Q2	$983K	Buy	3,140 +780	+33%	+$260K	0.19%	94
2019 Q1	$969K	Buy	+2,360	New	+$972K	0.19%	93

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Buckingham Capital Management (Ohio)'s REGN Position: Q1 2021 in Review

Buckingham Capital Management (Ohio) sold out of Regeneron Pharmaceuticals (REGN) in Q1 2021, closing a stake of 552 shares — an estimated $267K sold.

Buckingham Capital Management (Ohio) first reported a position in REGN in Q1 2019 and held it in 8 quarters. The position peaked at $983K in Q2 2019. 924 funds tracked by Wall St. Rank hold REGN as of Q1 2021.

Buckingham Capital Management (Ohio) reported no remaining Regeneron Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Buckingham Capital Management (Ohio) sold 552 Regeneron Pharmaceuticals shares in Q1 2021, an estimated $267K.
Buckingham Capital Management (Ohio) first reported a position in Regeneron Pharmaceuticals in Q1 2019 and held it in 8 quarters.
Buckingham Capital Management (Ohio)'s Regeneron Pharmaceuticals position peaked at $983K in Q2 2019.
924 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2021.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q1 2021, filed 4 May 2021.